Cantitate/Preț
Produs

Biological Drug Products – Development and Strategies

Autor W Wang
en Limba Engleză Hardback – 28 noi 2013
Tested and proven solutions to the challenges of biological drug product development Biological drug products play a central role in combating human diseases; however, developing new successful biological drugs presents many challenges, including labor intensive production processes, tighter regulatory controls, and increased market competition. This book reviews the current state of the science, offering readers a single resource that sets forth the fundamentals as well as tested and proven development strategies for biological drugs. Moreover, the book prepares readers for the challenges that typically arise during drug development, offering straightforward solutions to improve their ability to pass through all the regulatory hurdles and deliver new drug products to the market. Biological Drug Products begins with general considerations for the development of any biological drug product and then explores the strategies and challenges involved in the development of specific types of biologics. Divided into five parts, the book examines: * Part 1: General Aspects * Part 2: Proteins and Peptides * Part 3: Vaccines * Part 4: Novel Biologics * Part 5: Product Administration/Delivery Each chapter has been prepared by one or more leading experts in biological drug development. Contributions are based on a comprehensive review and analysis of the current literature as well as the authors' first-hand experience developing and testing new drugs. References at the end of each chapter serve as a gateway to original research papers and reviews in the field. By incorporating lessons learned and future directions for research, Biological Drug Products enables pharmaceutical scientists and students to improve their success rate in developing new biologics to treat a broad range of human diseases.
Citește tot Restrânge

Preț: 117688 lei

Preț vechi: 123882 lei
-5% Nou

Puncte Express: 1765

Preț estimativ în valută:
22521 23543$ 19031£

Carte tipărită la comandă

Livrare economică 06-20 martie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781118148891
ISBN-10: 1118148894
Pagini: 744
Dimensiuni: 156 x 234 x 41 mm
Greutate: 1.12 kg
Ediția:New.
Editura: Wiley
Locul publicării:Hoboken, United States

Public țintă

Pharmaceutical and biotech scientists, pharmacologists, medicinal chemists, formulations scientists Biological and biochemical engineers, protein scientists, molecular biologists, toxicologists, clinical researchers
Government regulatory bodies FDA (USA), EMEA (Europe), PMDA (Japan), NICPBP (China) and equivalent agencies
Academic biotechnology, drug development, pharmaceutical, and pharmacy programs

Cuprins


Notă biografică

WEI WANG, PhD, is a Research Fellow for Pfizer BioTherapeutics Pharmaceutical Sciences. In addition, Dr. Wang is Adjunct Professor in the School of Pharmacy and Health Sciences at the University of the Pacific. MANMOHAN SINGH, PhD, is Head of Technical Development at Novartis Vaccines and Diagnostics. Dr. Singh has authored over 120 peer-reviewed manuscripts, reviews, and book chapters in the area of vaccine formulations and adjuvant research. He is also an Adjunct Professor at the Eshelman School of Pharmacy at University of North Carolina, Chapel Hill.

Descriere

This book overviews the fundamental aspects, challenges, and strategies for developing a variety of biological drugs -- a large and growing segment of the pharmaceutical industry. Contributing authors discuss the development process, safety and clinical assessments, manufacturing, regulatory and intellectual property issues.